DERMATOMYOSITIS (DM)
Clinical trials for DERMATOMYOSITIS (DM) explained in plain language.
Never miss a new study
Get alerted when new DERMATOMYOSITIS (DM) trials appear
Sign up with your email to follow new studies for DERMATOMYOSITIS (DM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug RAY121 tested for Long-Term safety in autoimmune patients
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a drug called RAY121 in people with certain immune system diseases, such as antiphospholipid syndrome, bullous pemphigoid, and immune thrombocytopenia. About 144 participants who have already received four doses of RAY121 in a previous …
Matched conditions: DERMATOMYOSITIS (DM)
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 17, 2026 10:09 UTC
-
AI and PET scans join forces to spot lung trouble in rare muscle disease
Knowledge-focused OngoingThis study aims to create a better way to diagnose interstitial lung disease (ILD) in people with dermatomyositis, a rare muscle condition. Researchers will use special PET/CT scans and machine learning to find patterns that predict ILD. The study involves 200 adults and compares…
Matched conditions: DERMATOMYOSITIS (DM)
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC